Reading is good for you...
Reading about what's good for you is even better.
December 18, 2023
December 14, 2023
August 8, 2022
Get your Abraxane delivered at your door for FREE
Paclitaxel belongs to the group of cancer-fighting medications known as antineoplastics. Paclitaxel works by slowing or stopping the growth of cancer cells in your body.
Medication pricing not available right now.
Please message us or give us a call at 1-855-950-7225.
Paclitaxel belongs to the group of cancer-fighting medications known as antineoplastics. Paclitaxel works by slowing or stopping the growth of cancer cells in your body. Paclitaxel is used alone or in combination with other cancer medications to treat cancers of the ovary, breast, or lung. It may also be used to treat another form of cancer called Kaposi's sarcoma.
Nab-paclitaxel is a slightly different form of the same medication. It is used alone or in combination with other cancer medications to treat Breast Cancer that has spread (metastasized), or in combination with other medications to treat cancer of the pancreas that has metastasized.
Abraxane (Paclitaxel-nanoparticles) may be available under multiple brand names and/or in several different forms. Any specific brand name of Abraxane (Paclitaxel-nanoparticles) may not be available in all of the forms or approved for all of the conditions discussed here. As well, some forms of Abraxane (Paclitaxel-nanoparticles) may not be used for all of the conditions discussed here.
Your doctor may have suggested Abraxane (Paclitaxel-nanoparticles) for conditions other than those listed in these drug information articles. If you have not discussed this with your doctor or are not sure why you are taking Abraxane (Paclitaxel-nanoparticles), speak to your doctor.
The recommended dose and dosing schedule of paclitaxel varies according to the specific type of cancer being treated, the response to treatment, and other medications or treatments being used. The dose given is also based on body size. Paclitaxel is usually injected into a vein (intravenously) by a qualified health care professional through a specially prepared site on your skin. It is often given as an infusion over 30 to 40 minutes.
Many things can affect the dose of medication that a person needs, such as body weight, other medical conditions, and other medications. Very careful handling of Abraxane (Paclitaxel-nanoparticles) is required. It is always given under the supervision of a doctor in a hospital or similar setting with access to sterile equipment for preparation.
It is important Abraxane (Paclitaxel-nanoparticles) be given exactly as recommended by your doctor. If you miss an appointment to receive paclitaxel, contact your doctor as soon as possible to reschedule your appointment.
Store Abraxane (Paclitaxel-nanoparticles) at room temperature, protect it from light and moisture, and keep it out of the reach of children.
Do not dispose of medications in wastewater (e.g. down the sink or in the toilet) or in household garbage. Ask your pharmacist how to dispose of medications that are no longer needed or have expired.
Many medications can cause side effects. A side effect is an unwanted response to a medication when it is taken in normal doses. Side effects can be mild or severe, temporary or permanent.
The side effects listed below are not experienced by everyone who takes this medication. If you are concerned about side effects, discuss the risks and benefits of Abraxane (Paclitaxel-nanoparticles) with your doctor.
The following side effects have been reported by at least 1% of people taking Abraxane (Paclitaxel-nanoparticles). Many of these side effects can be managed, and some may go away on their own over time.
Contact your doctor if you experience these side effects and they are severe or bothersome. Your pharmacist may be able to advise you on managing side effects.
Although most of the side effects listed below don't happen very often, they could lead to serious problems if you do not seek medical attention.
Check with your doctor as soon as possible if any of the following side effects occur:
Stop taking the medication and seek immediate medical attention if any of the following occur:
Some people may experience side effects other than those listed. Check with your doctor if you notice any symptom that worries you while you are taking Abraxane (Paclitaxel-nanoparticles).
Abraxane for Injectable Suspension (paclitaxel powder for injectable suspension) (nanoparticle, albumin-bound [nab] paclitaxel) is supplied as a white-to-yellow, sterile, lyophilized cake for reconstitution with 20 mL of 0.9% Sodium Chloride Injection, USP prior to intravenous infusion. Each single use vial contains 100 mg of paclitaxel and approximately 900 mg of human Albumin. Each mL of reconstituted suspension contains 5 mg paclitaxel. Abraxane does not contain solvents.
Do not use paclitaxel if you:
There may be an interaction between paclitaxel and any of the following:
If you are taking any of these medications, speak with your doctor or pharmacist. Depending on your specific circumstances, your doctor may want you to:
An interaction between two medications does not always mean that you must stop taking one of them. Speak to your doctor about how any drug interactions are being managed or should be managed.
Medications other than those listed above may interact with this medication. Tell your doctor or prescriber about all prescription, over-the-counter (non-prescription), and herbal medications you are taking. Also tell them about any supplements you take. Since caffeine, alcohol, the Nicotine from cigarettes, or street drugs can affect the action of many medications, you should let your prescriber know if you use them.
Before you begin using a medication, be sure to inform your doctor of any medical conditions or Allergies you may have, any medications you are taking, whether you are pregnant or breast-feeding, and any other significant facts about your health. These factors may affect how you should use Abraxane (Paclitaxel-nanoparticles).
Allergic reactions: Abraxane (Paclitaxel-nanoparticles) may cause an allergic reaction (flushing of the face, severe back pain, chest tightness, shortness of breath) within the first few minutes of receiving paclitaxel. You will be asked to take some medication prior to treatment with paclitaxel to reduce your chances of experiencing a reaction.
Arrhythmia: People with heart rhythm problems may experience a worsening of these problems due to this medication. If you have a heart problem, discuss with your doctor how this medication may affect your medical condition, how your medical condition may affect the dosing and effectiveness of Abraxane (Paclitaxel-nanoparticles), and whether any special monitoring is needed.
Blood clotting: Abraxane (Paclitaxel-nanoparticles) can reduce the number of platelet cells in the blood. Platelets help the blood to clot, and a shortage could make you bleed more easily. Tell your doctor of any signs that your blood is not clotting as quickly as usual. Such symptoms may include black and tarry stools, blood in the urine, easy bruising, or cuts that do not stop bleeding.
Drowsiness/reduced alertness: Abraxane (Paclitaxel-nanoparticles) may cause fatigue and weakness which may affect the mental or physical abilities needed to drive or operate machinery. Avoid driving, operating machinery, or performing other hazardous tasks until you have determined how Abraxane (Paclitaxel-nanoparticles) affects you.
Eye problems: Paclitaxel may cause a rare eye problem called cystoid macular edema, which reults in blurred vision due to swelling of the Retin A. If you notice blurred vision or any other vision changes, notify your doctor immediately.
Infection: As well as killing cancer cells, Abraxane (Paclitaxel-nanoparticles) can reduce the number of cells that fight infection in the body (white blood cells). Avoid contact with people who have a contagious infection and tell your doctor immediately if you begin to notice signs of an infection, such as fever or chills.
Liver function: Liver disease or reduced liver function may cause increased side effects with Abraxane (Paclitaxel-nanoparticles). If you have liver problems, discuss with your doctor how Abraxane (Paclitaxel-nanoparticles) may affect your medical condition, how your medical condition may affect the dosing and effectiveness of this medication, and whether any special monitoring is needed. Your doctor will test your liver function regularly with blood tests while you are taking this medication.
If you experience symptoms of liver problems such as fatigue, feeling unwell, loss of appetite, nausea, yellowing of the skin or whites of the eyes, dark urine, pale stools, abdominal pain or swelling, and itchy skin, contact your doctor immediately.
Nerve pain: Paclitaxel may cause a mild burning, tingling, or numbing sensation of the fingers and toes. This side effect is rarely severe and usually goes away once you finish treatment.
Pregnancy: There are no adequate studies of use of Abraxane (Paclitaxel-nanoparticles) by pregnant women, however paclitaxel may cause severe harm to a developing baby if it is used by the mother during pregnancy. Abraxane (Paclitaxel-nanoparticles) should not be used during pregnancy. If you become pregnant while taking Abraxane (Paclitaxel-nanoparticles), contact your doctor immediately.
Breast-feeding: It is not known if paclitaxel passes into breast milk. If you are a breast-feeding mother and are taking Abraxane (Paclitaxel-nanoparticles), it may affect your baby. Talk to your doctor about whether you should continue breast-feeding.
Children: The safety and effectiveness of using Abraxane (Paclitaxel-nanoparticles) have not been established for children.
Seniors: People over the age of 65 may be at increased risk of side effects from Abraxane (Paclitaxel-nanoparticles).
All material © 1996-2021 MediResource Inc. Terms and conditions of use. The contents herein are for informational purposes only. Always seek the advice of your physician or other qualified health providers with any questions you may have regarding a medical condition.
December 18, 2023
December 14, 2023
August 8, 2022